Intawat Nookaew
Concepts (645)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 11 | 2024 | 170 | 2.980 |
Why?
| Saccharomyces cerevisiae | 19 | 2021 | 189 | 2.880 |
Why?
| Software | 11 | 2024 | 271 | 2.150 |
Why?
| Genomics | 14 | 2023 | 285 | 2.030 |
Why?
| Genome, Fungal | 10 | 2020 | 39 | 1.900 |
Why?
| Phylogeny | 11 | 2023 | 234 | 1.850 |
Why?
| Metagenome | 9 | 2024 | 40 | 1.820 |
Why?
| Genome | 6 | 2022 | 65 | 1.770 |
Why?
| Gene Expression Profiling | 28 | 2024 | 1037 | 1.660 |
Why?
| Bacteria | 13 | 2020 | 222 | 1.640 |
Why?
| Transcriptome | 19 | 2024 | 320 | 1.630 |
Why?
| Genome, Viral | 6 | 2020 | 79 | 1.580 |
Why?
| Metabolic Networks and Pathways | 14 | 2021 | 89 | 1.490 |
Why?
| Osteocytes | 5 | 2024 | 215 | 1.430 |
Why?
| Computational Biology | 9 | 2024 | 216 | 1.400 |
Why?
| Sequence Analysis, DNA | 9 | 2024 | 238 | 1.380 |
Why?
| Models, Biological | 15 | 2020 | 723 | 1.340 |
Why?
| Metagenomics | 6 | 2024 | 40 | 1.280 |
Why?
| Nanopores | 3 | 2022 | 4 | 1.150 |
Why?
| Systems Biology | 8 | 2016 | 33 | 1.150 |
Why?
| DNA, Circular | 2 | 2022 | 18 | 1.050 |
Why?
| Sequence Analysis, RNA | 8 | 2022 | 91 | 1.030 |
Why?
| Gastrointestinal Tract | 10 | 2020 | 101 | 0.960 |
Why?
| Genetic Variation | 6 | 2020 | 213 | 0.920 |
Why?
| Periosteum | 1 | 2024 | 26 | 0.920 |
Why?
| Databases, Genetic | 9 | 2020 | 88 | 0.900 |
Why?
| Animals | 47 | 2024 | 13246 | 0.860 |
Why?
| Mice | 32 | 2024 | 5759 | 0.830 |
Why?
| Lipid Metabolism | 7 | 2019 | 175 | 0.810 |
Why?
| RNA, Fungal | 2 | 2021 | 21 | 0.810 |
Why?
| Osteoblasts | 2 | 2024 | 450 | 0.790 |
Why?
| Genome, Bacterial | 12 | 2020 | 125 | 0.790 |
Why?
| Virulence | 3 | 2020 | 173 | 0.780 |
Why?
| Streptococcus suis | 1 | 2020 | 1 | 0.750 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2021 | 24 | 0.750 |
Why?
| Drug Resistance, Microbial | 1 | 2020 | 46 | 0.750 |
Why?
| Geography | 1 | 2020 | 60 | 0.740 |
Why?
| Signal Transduction | 13 | 2024 | 1622 | 0.720 |
Why?
| DNA Adducts | 1 | 2020 | 77 | 0.710 |
Why?
| Herpesviridae | 1 | 2020 | 17 | 0.710 |
Why?
| Oligonucleotide Array Sequence Analysis | 11 | 2018 | 411 | 0.710 |
Why?
| Helicobacter pylori | 3 | 2017 | 65 | 0.700 |
Why?
| Energy Metabolism | 5 | 2023 | 279 | 0.700 |
Why?
| DNA, Viral | 1 | 2020 | 134 | 0.680 |
Why?
| Metabolome | 8 | 2019 | 89 | 0.680 |
Why?
| Mitochondria | 4 | 2022 | 404 | 0.660 |
Why?
| Diet | 6 | 2019 | 557 | 0.620 |
Why?
| Single-Cell Analysis | 3 | 2024 | 61 | 0.610 |
Why?
| Saccharomyces cerevisiae Proteins | 5 | 2015 | 154 | 0.590 |
Why?
| Humans | 65 | 2024 | 50208 | 0.590 |
Why?
| Eicosapentaenoic Acid | 4 | 2019 | 20 | 0.580 |
Why?
| Docosahexaenoic Acids | 4 | 2019 | 27 | 0.580 |
Why?
| Diet, High-Fat | 7 | 2019 | 220 | 0.580 |
Why?
| Viruses | 1 | 2017 | 22 | 0.560 |
Why?
| Penaeidae | 3 | 2021 | 3 | 0.560 |
Why?
| Head and Neck Neoplasms | 1 | 2019 | 273 | 0.550 |
Why?
| Proteomics | 3 | 2018 | 330 | 0.520 |
Why?
| Fishes | 3 | 2013 | 19 | 0.500 |
Why?
| Gastritis, Atrophic | 2 | 2017 | 5 | 0.500 |
Why?
| RNA, Messenger | 9 | 2022 | 1108 | 0.480 |
Why?
| Adipose Tissue | 2 | 2013 | 187 | 0.480 |
Why?
| Gastric Mucosa | 2 | 2017 | 48 | 0.480 |
Why?
| Fatty Acids, Unsaturated | 4 | 2020 | 36 | 0.470 |
Why?
| Aspergillus oryzae | 4 | 2017 | 23 | 0.470 |
Why?
| Mice, Inbred C57BL | 14 | 2024 | 1819 | 0.450 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 4 | 2016 | 23 | 0.450 |
Why?
| Muscle, Smooth, Vascular | 3 | 2019 | 129 | 0.430 |
Why?
| Basal Metabolism | 1 | 2012 | 31 | 0.430 |
Why?
| Transcription, Genetic | 3 | 2021 | 369 | 0.430 |
Why?
| Proteome | 5 | 2019 | 173 | 0.420 |
Why?
| Metabolomics | 4 | 2021 | 125 | 0.420 |
Why?
| Spleen | 3 | 2019 | 172 | 0.420 |
Why?
| Adjuvants, Immunologic | 3 | 2019 | 51 | 0.400 |
Why?
| Osteolysis | 2 | 2022 | 75 | 0.400 |
Why?
| Hepatitis C | 2 | 2023 | 79 | 0.390 |
Why?
| Multiple Myeloma | 5 | 2024 | 2954 | 0.390 |
Why?
| Lipids | 4 | 2019 | 148 | 0.380 |
Why?
| Chlorobi | 1 | 2011 | 4 | 0.380 |
Why?
| Bacteroidetes | 1 | 2011 | 5 | 0.380 |
Why?
| RNA, Ribosomal, 16S | 7 | 2024 | 112 | 0.380 |
Why?
| Glioma | 2 | 2023 | 79 | 0.380 |
Why?
| Meiosis | 2 | 2021 | 56 | 0.380 |
Why?
| Enterotoxigenic Escherichia coli | 2 | 2022 | 3 | 0.380 |
Why?
| Bone Diseases, Metabolic | 2 | 2022 | 74 | 0.380 |
Why?
| Male | 32 | 2021 | 25399 | 0.370 |
Why?
| Biology | 1 | 2010 | 8 | 0.370 |
Why?
| Sterols | 1 | 2010 | 8 | 0.370 |
Why?
| Reproducibility of Results | 11 | 2020 | 1185 | 0.360 |
Why?
| Escherichia coli Proteins | 2 | 2022 | 56 | 0.360 |
Why?
| Bone Resorption | 2 | 2023 | 302 | 0.360 |
Why?
| Gene Regulatory Networks | 4 | 2021 | 107 | 0.360 |
Why?
| Gene Expression Regulation | 15 | 2020 | 979 | 0.350 |
Why?
| T-Lymphocytes | 5 | 2023 | 339 | 0.350 |
Why?
| Cytokines | 5 | 2023 | 613 | 0.340 |
Why?
| Phospholipids | 3 | 2021 | 57 | 0.340 |
Why?
| Female | 30 | 2024 | 26635 | 0.330 |
Why?
| DNA | 3 | 2022 | 541 | 0.330 |
Why?
| RNA Interference | 2 | 2019 | 179 | 0.330 |
Why?
| Carcinoma, Hepatocellular | 2 | 2022 | 193 | 0.330 |
Why?
| Aged | 15 | 2024 | 9405 | 0.330 |
Why?
| RNA | 4 | 2022 | 171 | 0.330 |
Why?
| HIV Infections | 2 | 2023 | 357 | 0.320 |
Why?
| Myocytes, Smooth Muscle | 2 | 2019 | 86 | 0.310 |
Why?
| Brain Neoplasms | 2 | 2023 | 288 | 0.310 |
Why?
| Bone Density | 3 | 2022 | 379 | 0.310 |
Why?
| Tumor Microenvironment | 3 | 2024 | 233 | 0.310 |
Why?
| Algorithms | 4 | 2024 | 618 | 0.310 |
Why?
| Bifidobacterium | 2 | 2020 | 7 | 0.310 |
Why?
| Cell Differentiation | 6 | 2022 | 650 | 0.310 |
Why?
| Liver Neoplasms | 2 | 2022 | 328 | 0.300 |
Why?
| Microcephaly | 2 | 2018 | 41 | 0.300 |
Why?
| MicroRNAs | 3 | 2019 | 355 | 0.300 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 41 | 0.300 |
Why?
| Plant Extracts | 2 | 2020 | 171 | 0.290 |
Why?
| Proteins | 1 | 2010 | 345 | 0.290 |
Why?
| Internet | 5 | 2017 | 258 | 0.280 |
Why?
| Feces | 4 | 2020 | 131 | 0.280 |
Why?
| Osteoclasts | 4 | 2024 | 428 | 0.280 |
Why?
| Immune System | 3 | 2016 | 43 | 0.270 |
Why?
| Polymerase Chain Reaction | 4 | 2021 | 454 | 0.270 |
Why?
| Middle Aged | 13 | 2021 | 12206 | 0.270 |
Why?
| Malates | 3 | 2017 | 7 | 0.270 |
Why?
| Neutrophils | 2 | 2019 | 148 | 0.270 |
Why?
| Populus | 2 | 2015 | 8 | 0.260 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2020 | 485 | 0.260 |
Why?
| Arachidonic Acid | 3 | 2020 | 34 | 0.260 |
Why?
| Recombination, Genetic | 3 | 2021 | 96 | 0.250 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2018 | 486 | 0.250 |
Why?
| Hemiptera | 2 | 2021 | 4 | 0.250 |
Why?
| Plasmids | 3 | 2020 | 161 | 0.250 |
Why?
| Bone and Bones | 4 | 2023 | 475 | 0.240 |
Why?
| Chromosome Mapping | 3 | 2017 | 156 | 0.240 |
Why?
| Chemokine CXCL12 | 1 | 2024 | 32 | 0.240 |
Why?
| Isocitrate Dehydrogenase | 2 | 2023 | 17 | 0.240 |
Why?
| Biomass | 3 | 2015 | 18 | 0.240 |
Why?
| Mice, Knockout | 3 | 2023 | 846 | 0.240 |
Why?
| Leukocytes, Mononuclear | 2 | 2022 | 115 | 0.230 |
Why?
| Homeodomain Proteins | 2 | 2022 | 80 | 0.230 |
Why?
| Aquaculture | 2 | 2021 | 4 | 0.230 |
Why?
| Carcinoma, Renal Cell | 2 | 2016 | 105 | 0.230 |
Why?
| Chondrocytes | 1 | 2024 | 41 | 0.230 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 828 | 0.230 |
Why?
| Adipose Tissue, White | 3 | 2019 | 34 | 0.230 |
Why?
| Thailand | 2 | 2020 | 8 | 0.230 |
Why?
| Inflammation | 6 | 2023 | 604 | 0.230 |
Why?
| Bacteriological Techniques | 2 | 2020 | 41 | 0.230 |
Why?
| Antiviral Agents | 2 | 2023 | 173 | 0.230 |
Why?
| Oligodendroglioma | 1 | 2023 | 6 | 0.230 |
Why?
| Organ Specificity | 2 | 2016 | 108 | 0.220 |
Why?
| Astrocytoma | 1 | 2023 | 20 | 0.220 |
Why?
| Adenine | 2 | 2021 | 32 | 0.220 |
Why?
| NAD | 1 | 2023 | 43 | 0.220 |
Why?
| Genome Size | 3 | 2020 | 9 | 0.220 |
Why?
| Transcription Factors | 9 | 2023 | 564 | 0.220 |
Why?
| Rhamnaceae | 1 | 2023 | 1 | 0.220 |
Why?
| Cell Line, Tumor | 6 | 2024 | 1416 | 0.220 |
Why?
| Genome, Chloroplast | 1 | 2023 | 2 | 0.220 |
Why?
| Cell Line | 3 | 2021 | 1021 | 0.220 |
Why?
| Osteogenesis | 3 | 2022 | 353 | 0.220 |
Why?
| Molecular Sequence Data | 5 | 2018 | 793 | 0.210 |
Why?
| Eukaryotic Cells | 1 | 2022 | 19 | 0.210 |
Why?
| Staphylococcus aureus | 3 | 2021 | 327 | 0.210 |
Why?
| Pilot Projects | 3 | 2020 | 697 | 0.210 |
Why?
| Oxidative Phosphorylation | 2 | 2020 | 40 | 0.210 |
Why?
| Microbial Sensitivity Tests | 2 | 2020 | 270 | 0.210 |
Why?
| Pichia | 2 | 2012 | 8 | 0.210 |
Why?
| Base Sequence | 4 | 2021 | 644 | 0.210 |
Why?
| Bone Neoplasms | 1 | 2024 | 183 | 0.210 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.210 |
Why?
| Hepatitis C, Chronic | 1 | 2023 | 83 | 0.210 |
Why?
| Escherichia coli Infections | 1 | 2022 | 31 | 0.210 |
Why?
| Cyclic AMP | 1 | 2022 | 91 | 0.210 |
Why?
| Escherichia coli | 2 | 2021 | 186 | 0.210 |
Why?
| Estrogens | 2 | 2022 | 228 | 0.200 |
Why?
| Drug Resistance, Neoplasm | 1 | 2024 | 314 | 0.200 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 157 | 0.200 |
Why?
| Spermatozoa | 1 | 2021 | 23 | 0.200 |
Why?
| Phenotype | 5 | 2023 | 733 | 0.200 |
Why?
| Chemotaxis | 2 | 2019 | 23 | 0.200 |
Why?
| Principal Component Analysis | 4 | 2016 | 55 | 0.200 |
Why?
| Chromosomes, Human | 1 | 2021 | 41 | 0.200 |
Why?
| Cell Communication | 1 | 2022 | 69 | 0.200 |
Why?
| Benzofurans | 1 | 2021 | 18 | 0.200 |
Why?
| Quinoxalines | 1 | 2021 | 27 | 0.200 |
Why?
| Case-Control Studies | 8 | 2018 | 1126 | 0.200 |
Why?
| Adipose Tissue, Brown | 2 | 2019 | 40 | 0.200 |
Why?
| Neck Pain | 1 | 2021 | 10 | 0.190 |
Why?
| Coinfection | 1 | 2021 | 38 | 0.190 |
Why?
| Back Pain | 1 | 2021 | 39 | 0.190 |
Why?
| Arthralgia | 1 | 2021 | 43 | 0.190 |
Why?
| Adenosine Triphosphate | 2 | 2020 | 233 | 0.190 |
Why?
| Templates, Genetic | 1 | 2021 | 14 | 0.190 |
Why?
| Triglycerides | 2 | 2019 | 155 | 0.190 |
Why?
| RNA, Ribosomal | 1 | 2021 | 20 | 0.190 |
Why?
| User-Computer Interface | 3 | 2017 | 81 | 0.190 |
Why?
| Imidoesters | 1 | 2020 | 1 | 0.190 |
Why?
| Netherlands | 1 | 2020 | 17 | 0.190 |
Why?
| Swine Diseases | 1 | 2020 | 7 | 0.190 |
Why?
| Methyltransferases | 1 | 2021 | 29 | 0.190 |
Why?
| Nucleotide Motifs | 1 | 2021 | 24 | 0.190 |
Why?
| Professional-Patient Relations | 1 | 2021 | 47 | 0.190 |
Why?
| RNA, Bacterial | 1 | 2021 | 58 | 0.190 |
Why?
| Adult | 11 | 2022 | 13324 | 0.190 |
Why?
| Imidazoles | 1 | 2021 | 128 | 0.180 |
Why?
| China | 1 | 2020 | 88 | 0.180 |
Why?
| Canada | 1 | 2020 | 101 | 0.180 |
Why?
| Lactobacillus plantarum | 1 | 2020 | 1 | 0.180 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.180 |
Why?
| Surface Properties | 1 | 2020 | 72 | 0.180 |
Why?
| Stereoisomerism | 1 | 2020 | 103 | 0.180 |
Why?
| Host-Pathogen Interactions | 2 | 2019 | 135 | 0.180 |
Why?
| Muscle, Skeletal | 3 | 2016 | 765 | 0.180 |
Why?
| Particle Size | 1 | 2020 | 80 | 0.180 |
Why?
| DNA Modification Methylases | 1 | 2020 | 28 | 0.180 |
Why?
| Mortierella | 1 | 2020 | 1 | 0.180 |
Why?
| Acetyl Coenzyme A | 1 | 2020 | 6 | 0.180 |
Why?
| ROC Curve | 1 | 2021 | 232 | 0.180 |
Why?
| Streptococcal Infections | 1 | 2020 | 46 | 0.180 |
Why?
| DNA Repair Enzymes | 1 | 2020 | 44 | 0.180 |
Why?
| Alum Compounds | 1 | 2019 | 3 | 0.170 |
Why?
| Genome-Wide Association Study | 1 | 2020 | 166 | 0.170 |
Why?
| Cell Culture Techniques | 1 | 2020 | 99 | 0.170 |
Why?
| Helicobacter Infections | 2 | 2017 | 63 | 0.170 |
Why?
| Renal Insufficiency, Chronic | 1 | 2023 | 169 | 0.170 |
Why?
| Molecular Structure | 1 | 2020 | 296 | 0.170 |
Why?
| Colitis | 1 | 2020 | 51 | 0.170 |
Why?
| Tumor Suppressor Proteins | 1 | 2020 | 128 | 0.170 |
Why?
| Mumps virus | 1 | 2019 | 12 | 0.170 |
Why?
| Cannabidiol | 1 | 2020 | 38 | 0.170 |
Why?
| Mumps | 1 | 2019 | 14 | 0.170 |
Why?
| Swine | 1 | 2020 | 396 | 0.170 |
Why?
| Intestinal Mucosa | 3 | 2020 | 215 | 0.170 |
Why?
| Computer Simulation | 5 | 2013 | 280 | 0.170 |
Why?
| Cytoskeleton | 1 | 2019 | 41 | 0.170 |
Why?
| Databases, Protein | 3 | 2015 | 29 | 0.170 |
Why?
| Glycocholic Acid | 1 | 2019 | 1 | 0.170 |
Why?
| Cholagogues and Choleretics | 1 | 2019 | 6 | 0.170 |
Why?
| Stress, Mechanical | 1 | 2019 | 92 | 0.170 |
Why?
| Tea | 1 | 2019 | 17 | 0.160 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 18 | 0.160 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2020 | 164 | 0.160 |
Why?
| Ion Channels | 1 | 2019 | 76 | 0.160 |
Why?
| Microbial Viability | 2 | 2017 | 30 | 0.160 |
Why?
| Preservation, Biological | 1 | 2018 | 9 | 0.160 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2019 | 327 | 0.160 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 123 | 0.160 |
Why?
| Cell Death | 1 | 2019 | 182 | 0.160 |
Why?
| Liver | 5 | 2019 | 1116 | 0.160 |
Why?
| Sensitivity and Specificity | 2 | 2020 | 863 | 0.160 |
Why?
| Disease Models, Animal | 6 | 2023 | 1458 | 0.160 |
Why?
| Chronic Pain | 1 | 2021 | 166 | 0.160 |
Why?
| Prediabetic State | 1 | 2018 | 19 | 0.160 |
Why?
| Disease Outbreaks | 1 | 2019 | 125 | 0.160 |
Why?
| Molecular Sequence Annotation | 4 | 2020 | 27 | 0.160 |
Why?
| 5' Untranslated Regions | 1 | 2018 | 31 | 0.160 |
Why?
| Bacterial Physiological Phenomena | 2 | 2020 | 6 | 0.160 |
Why?
| Cecum | 1 | 2018 | 63 | 0.160 |
Why?
| Cell Movement | 1 | 2019 | 249 | 0.150 |
Why?
| 3' Untranslated Regions | 1 | 2018 | 52 | 0.150 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 96 | 0.150 |
Why?
| Obesity | 3 | 2016 | 1108 | 0.150 |
Why?
| Duodenum | 1 | 2017 | 35 | 0.150 |
Why?
| Cell Adhesion | 2 | 2015 | 158 | 0.150 |
Why?
| Neural Stem Cells | 1 | 2017 | 26 | 0.150 |
Why?
| Epithelial Cells | 2 | 2019 | 207 | 0.150 |
Why?
| Cannabis | 1 | 2020 | 145 | 0.150 |
Why?
| Pregnancy Complications, Infectious | 1 | 2018 | 73 | 0.150 |
Why?
| Tandem Repeat Sequences | 1 | 2017 | 7 | 0.150 |
Why?
| Gene Expression | 3 | 2019 | 609 | 0.150 |
Why?
| Colitis, Ulcerative | 1 | 2017 | 50 | 0.150 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2019 | 191 | 0.140 |
Why?
| Eukaryota | 1 | 2017 | 11 | 0.140 |
Why?
| Calcium | 2 | 2016 | 400 | 0.140 |
Why?
| Lipid A | 1 | 2016 | 4 | 0.140 |
Why?
| Glucosides | 1 | 2016 | 13 | 0.140 |
Why?
| Oligodeoxyribonucleotides | 1 | 2016 | 29 | 0.140 |
Why?
| Sequence Alignment | 1 | 2017 | 122 | 0.140 |
Why?
| Germinal Center | 1 | 2016 | 23 | 0.140 |
Why?
| Stomach | 1 | 2017 | 79 | 0.140 |
Why?
| Protein Biosynthesis | 1 | 2019 | 254 | 0.140 |
Why?
| Genes, Fungal | 2 | 2013 | 29 | 0.140 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2016 | 42 | 0.140 |
Why?
| Autoimmunity | 2 | 2016 | 35 | 0.140 |
Why?
| Fungal Proteins | 3 | 2017 | 119 | 0.140 |
Why?
| Muscle Relaxation | 1 | 2016 | 15 | 0.140 |
Why?
| Protein Conformation | 1 | 2017 | 168 | 0.140 |
Why?
| Immunization | 2 | 2019 | 67 | 0.140 |
Why?
| Microwaves | 2 | 2013 | 11 | 0.140 |
Why?
| Glycosaminoglycans | 1 | 2016 | 19 | 0.140 |
Why?
| Nitrogen | 2 | 2013 | 67 | 0.140 |
Why?
| Meat | 2 | 2013 | 61 | 0.140 |
Why?
| Aging | 1 | 2021 | 688 | 0.130 |
Why?
| DNA, Bacterial | 2 | 2020 | 188 | 0.130 |
Why?
| Oligopeptides | 1 | 2016 | 91 | 0.130 |
Why?
| Running | 1 | 2016 | 17 | 0.130 |
Why?
| Adhesins, Bacterial | 1 | 2016 | 27 | 0.130 |
Why?
| Inositol | 2 | 2013 | 19 | 0.130 |
Why?
| Pseudomonas | 1 | 2015 | 7 | 0.130 |
Why?
| Coronary Artery Disease | 1 | 2019 | 276 | 0.130 |
Why?
| Analgesics, Opioid | 1 | 2021 | 557 | 0.130 |
Why?
| Aorta, Thoracic | 1 | 2016 | 92 | 0.130 |
Why?
| Mice, Transgenic | 3 | 2023 | 550 | 0.130 |
Why?
| Melanoma, Experimental | 1 | 2016 | 45 | 0.130 |
Why?
| Ebolavirus | 1 | 2015 | 7 | 0.130 |
Why?
| Cluster Analysis | 5 | 2014 | 235 | 0.130 |
Why?
| Metabolic Engineering | 2 | 2014 | 3 | 0.130 |
Why?
| Breast Neoplasms | 1 | 2024 | 1179 | 0.130 |
Why?
| Conjugation, Genetic | 1 | 2015 | 1 | 0.130 |
Why?
| Flocculation | 1 | 2015 | 1 | 0.130 |
Why?
| Mannose-Binding Lectins | 1 | 2015 | 10 | 0.130 |
Why?
| Killer Cells, Natural | 1 | 2016 | 107 | 0.130 |
Why?
| Plant Proteins | 1 | 2015 | 67 | 0.130 |
Why?
| Muscle Cells | 1 | 2015 | 22 | 0.130 |
Why?
| Comparative Genomic Hybridization | 2 | 2015 | 47 | 0.130 |
Why?
| Adipocytes | 2 | 2013 | 121 | 0.130 |
Why?
| Fatty Acids | 2 | 2013 | 145 | 0.120 |
Why?
| Dietary Fats, Unsaturated | 1 | 2014 | 3 | 0.120 |
Why?
| Bacterial Load | 1 | 2014 | 12 | 0.120 |
Why?
| Kidney Neoplasms | 1 | 2016 | 176 | 0.120 |
Why?
| Interleukin-6 | 1 | 2016 | 265 | 0.120 |
Why?
| Stomach Neoplasms | 1 | 2017 | 179 | 0.120 |
Why?
| Blood Glucose | 2 | 2016 | 435 | 0.120 |
Why?
| Database Management Systems | 1 | 2014 | 28 | 0.120 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2013 | 52 | 0.120 |
Why?
| Kidney Failure, Chronic | 1 | 2016 | 200 | 0.120 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2014 | 19 | 0.120 |
Why?
| Fatty Liver | 1 | 2015 | 127 | 0.120 |
Why?
| Myocardial Infarction | 1 | 2018 | 396 | 0.120 |
Why?
| Loss of Heterozygosity | 1 | 2014 | 77 | 0.110 |
Why?
| Models, Theoretical | 2 | 2013 | 174 | 0.110 |
Why?
| DNA Methylation | 1 | 2018 | 550 | 0.110 |
Why?
| Penicillium chrysogenum | 1 | 2013 | 1 | 0.110 |
Why?
| Fungi | 1 | 2013 | 44 | 0.110 |
Why?
| Glucose Intolerance | 1 | 2013 | 27 | 0.110 |
Why?
| Health | 1 | 2013 | 23 | 0.110 |
Why?
| United States | 2 | 2021 | 4874 | 0.110 |
Why?
| Genes | 1 | 2013 | 33 | 0.110 |
Why?
| Blood Vessels | 1 | 2013 | 71 | 0.110 |
Why?
| Carbon Isotopes | 4 | 2014 | 69 | 0.110 |
Why?
| Adipocytes, Brown | 1 | 2012 | 9 | 0.110 |
Why?
| INDEL Mutation | 1 | 2012 | 4 | 0.110 |
Why?
| Open Reading Frames | 2 | 2013 | 55 | 0.110 |
Why?
| Multiple Sclerosis | 1 | 2013 | 66 | 0.110 |
Why?
| Biosynthetic Pathways | 3 | 2020 | 6 | 0.110 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 9 | 0.100 |
Why?
| Industrial Microbiology | 1 | 2012 | 2 | 0.100 |
Why?
| Methyl Ethers | 1 | 2012 | 18 | 0.100 |
Why?
| Aldehyde-Lyases | 1 | 2012 | 1 | 0.100 |
Why?
| Aspergillus nidulans | 1 | 2012 | 5 | 0.100 |
Why?
| Leukocytes | 1 | 2012 | 67 | 0.100 |
Why?
| Choline | 1 | 2012 | 61 | 0.100 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2011 | 33 | 0.100 |
Why?
| Yeasts | 1 | 2011 | 10 | 0.100 |
Why?
| Hepacivirus | 2 | 2023 | 104 | 0.100 |
Why?
| Staphylococcal Infections | 1 | 2014 | 269 | 0.100 |
Why?
| Cell Proliferation | 2 | 2023 | 1013 | 0.100 |
Why?
| Sex Characteristics | 1 | 2012 | 191 | 0.100 |
Why?
| Insulin Resistance | 1 | 2013 | 262 | 0.090 |
Why?
| Amino Acid Sequence | 3 | 2018 | 586 | 0.090 |
Why?
| Vagina | 1 | 2011 | 45 | 0.090 |
Why?
| Gene Deletion | 2 | 2010 | 270 | 0.090 |
Why?
| Phosphoglycerate Mutase | 1 | 2010 | 1 | 0.090 |
Why?
| Adipocytes, White | 1 | 2010 | 3 | 0.090 |
Why?
| Bone Marrow | 1 | 2012 | 363 | 0.090 |
Why?
| Aspergillus niger | 1 | 2010 | 7 | 0.090 |
Why?
| Homeostasis | 2 | 2023 | 201 | 0.090 |
Why?
| RANK Ligand | 2 | 2022 | 179 | 0.090 |
Why?
| Genotype | 2 | 2023 | 534 | 0.090 |
Why?
| Time Factors | 4 | 2019 | 2922 | 0.090 |
Why?
| Mutation | 3 | 2023 | 1294 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 136 | 0.080 |
Why?
| Drug Combinations | 2 | 2021 | 126 | 0.080 |
Why?
| Microarray Analysis | 3 | 2015 | 73 | 0.080 |
Why?
| Atherosclerosis | 1 | 2012 | 214 | 0.080 |
Why?
| Immunity, Innate | 2 | 2020 | 105 | 0.080 |
Why?
| RNA, Transfer | 1 | 2008 | 16 | 0.080 |
Why?
| Pregnancy | 4 | 2018 | 2604 | 0.080 |
Why?
| Corn Oil | 2 | 2019 | 12 | 0.080 |
Why?
| Gas Chromatography-Mass Spectrometry | 3 | 2013 | 67 | 0.080 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 181 | 0.080 |
Why?
| Antigens, Bacterial | 2 | 2019 | 54 | 0.080 |
Why?
| Energy Transfer | 1 | 2007 | 2 | 0.080 |
Why?
| Chromatography, Liquid | 2 | 2019 | 225 | 0.070 |
Why?
| Cross-Sectional Studies | 1 | 2012 | 1554 | 0.070 |
Why?
| Multilocus Sequence Typing | 2 | 2018 | 14 | 0.070 |
Why?
| Young Adult | 4 | 2020 | 3981 | 0.070 |
Why?
| Sequence Homology, Amino Acid | 2 | 2018 | 144 | 0.070 |
Why?
| Fatty Acids, Omega-3 | 2 | 2019 | 27 | 0.070 |
Why?
| Lymphocyte Activation | 2 | 2020 | 172 | 0.070 |
Why?
| Codon | 2 | 2017 | 47 | 0.070 |
Why?
| Infant | 3 | 2020 | 3563 | 0.070 |
Why?
| Aged, 80 and over | 1 | 2013 | 3154 | 0.070 |
Why?
| Bayes Theorem | 2 | 2017 | 109 | 0.060 |
Why?
| Tandem Mass Spectrometry | 2 | 2018 | 231 | 0.060 |
Why?
| Organ Size | 2 | 2016 | 225 | 0.060 |
Why?
| Child | 4 | 2022 | 6851 | 0.060 |
Why?
| Cells, Cultured | 2 | 2020 | 1581 | 0.060 |
Why?
| NF-kappa B | 2 | 2017 | 315 | 0.060 |
Why?
| Arkansas | 2 | 2021 | 1985 | 0.060 |
Why?
| Interleukin-18 | 1 | 2024 | 27 | 0.060 |
Why?
| Coenzyme A-Transferases | 1 | 2023 | 1 | 0.060 |
Why?
| Myeloid Progenitor Cells | 1 | 2023 | 18 | 0.060 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2023 | 8 | 0.060 |
Why?
| Osteoprotegerin | 1 | 2023 | 52 | 0.060 |
Why?
| Rats, Sprague-Dawley | 2 | 2018 | 1586 | 0.060 |
Why?
| Chloroplasts | 1 | 2023 | 5 | 0.050 |
Why?
| Eating | 1 | 2024 | 161 | 0.050 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2023 | 10 | 0.050 |
Why?
| Fermentation | 2 | 2013 | 8 | 0.050 |
Why?
| Bacterial Proteins | 2 | 2018 | 376 | 0.050 |
Why?
| Cattle | 2 | 2013 | 219 | 0.050 |
Why?
| Absorptiometry, Photon | 2 | 2013 | 153 | 0.050 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2023 | 93 | 0.050 |
Why?
| TNF Receptor-Associated Factor 3 | 1 | 2022 | 13 | 0.050 |
Why?
| Cystatin M | 1 | 2022 | 20 | 0.050 |
Why?
| Culture Media | 2 | 2013 | 93 | 0.050 |
Why?
| Fucose | 1 | 2022 | 1 | 0.050 |
Why?
| Putrescine | 1 | 2022 | 4 | 0.050 |
Why?
| Genome, Human | 2 | 2013 | 111 | 0.050 |
Why?
| Carbon | 2 | 2013 | 54 | 0.050 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2022 | 30 | 0.050 |
Why?
| Glycolysis | 2 | 2013 | 70 | 0.050 |
Why?
| Prognosis | 2 | 2021 | 1954 | 0.050 |
Why?
| Neurotransmitter Agents | 1 | 2022 | 35 | 0.050 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 51 | 0.050 |
Why?
| Amino Acids, Essential | 1 | 2024 | 131 | 0.050 |
Why?
| Infant, Newborn | 2 | 2020 | 2766 | 0.050 |
Why?
| Alu Elements | 1 | 2021 | 7 | 0.050 |
Why?
| Oxidation-Reduction | 1 | 2023 | 320 | 0.050 |
Why?
| Ovariectomy | 1 | 2022 | 117 | 0.050 |
Why?
| Neoplasms | 1 | 2012 | 1249 | 0.050 |
Why?
| Tryptophan | 1 | 2022 | 99 | 0.050 |
Why?
| Genes, Essential | 1 | 2021 | 11 | 0.050 |
Why?
| Mutagenesis, Insertional | 1 | 2021 | 24 | 0.050 |
Why?
| Gene Library | 1 | 2021 | 43 | 0.050 |
Why?
| Suramin | 1 | 2021 | 12 | 0.050 |
Why?
| Sulfoxides | 1 | 2021 | 19 | 0.050 |
Why?
| Viral Load | 1 | 2021 | 77 | 0.050 |
Why?
| Isothiocyanates | 1 | 2021 | 17 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2021 | 107 | 0.050 |
Why?
| Apoptosis | 2 | 2020 | 1112 | 0.050 |
Why?
| Iron | 1 | 2022 | 122 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2021 | 99 | 0.050 |
Why?
| Longitudinal Studies | 1 | 2023 | 695 | 0.050 |
Why?
| Chromosomes | 1 | 2021 | 33 | 0.050 |
Why?
| Clostridium | 1 | 2020 | 15 | 0.050 |
Why?
| Enterococcus | 1 | 2020 | 10 | 0.050 |
Why?
| Amino Acids | 2 | 2013 | 362 | 0.050 |
Why?
| Adolescent | 3 | 2017 | 6390 | 0.050 |
Why?
| Rats | 2 | 2018 | 3299 | 0.050 |
Why?
| Food Safety | 1 | 2020 | 3 | 0.050 |
Why?
| Drug Prescriptions | 1 | 2021 | 97 | 0.050 |
Why?
| Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.050 |
Why?
| Mucin-2 | 1 | 2020 | 7 | 0.050 |
Why?
| Cohort Studies | 2 | 2016 | 1422 | 0.050 |
Why?
| Membrane Proteins | 1 | 2023 | 353 | 0.050 |
Why?
| gamma-Linolenic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| Fatty Acid Desaturases | 1 | 2020 | 9 | 0.040 |
Why?
| Mucorales | 1 | 2020 | 11 | 0.040 |
Why?
| Dietary Supplements | 1 | 2024 | 434 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2021 | 454 | 0.040 |
Why?
| Cell Count | 1 | 2020 | 149 | 0.040 |
Why?
| Methylation | 1 | 2020 | 123 | 0.040 |
Why?
| Dydrogesterone | 1 | 2019 | 1 | 0.040 |
Why?
| Chemokines | 1 | 2020 | 78 | 0.040 |
Why?
| Workflow | 1 | 2020 | 51 | 0.040 |
Why?
| Disease Resistance | 1 | 2019 | 5 | 0.040 |
Why?
| Tuberculosis Vaccines | 1 | 2019 | 2 | 0.040 |
Why?
| Lentivirus | 1 | 2019 | 16 | 0.040 |
Why?
| Transduction, Genetic | 1 | 2019 | 45 | 0.040 |
Why?
| Child, Preschool | 2 | 2020 | 3883 | 0.040 |
Why?
| Transgenes | 1 | 2019 | 54 | 0.040 |
Why?
| Colon | 1 | 2020 | 94 | 0.040 |
Why?
| Gene Expression Regulation, Plant | 1 | 2019 | 42 | 0.040 |
Why?
| Mumps Vaccine | 1 | 2019 | 6 | 0.040 |
Why?
| Indoles | 1 | 2022 | 278 | 0.040 |
Why?
| Ovary | 1 | 2020 | 115 | 0.040 |
Why?
| Neutralization Tests | 1 | 2019 | 24 | 0.040 |
Why?
| Nanofibers | 1 | 2019 | 7 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 89 | 0.040 |
Why?
| Focal Adhesions | 1 | 2019 | 14 | 0.040 |
Why?
| PPAR alpha | 1 | 2019 | 58 | 0.040 |
Why?
| Lipid Peroxidation | 1 | 2019 | 100 | 0.040 |
Why?
| Actin Cytoskeleton | 1 | 2019 | 23 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 2019 | 161 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 106 | 0.040 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 56 | 0.040 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 61 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2023 | 613 | 0.040 |
Why?
| Genetic Vectors | 1 | 2019 | 125 | 0.040 |
Why?
| Cellular Microenvironment | 1 | 2019 | 26 | 0.040 |
Why?
| Antibodies, Neutralizing | 1 | 2019 | 64 | 0.040 |
Why?
| Caco-2 Cells | 1 | 2019 | 26 | 0.040 |
Why?
| Bacterial Adhesion | 1 | 2019 | 15 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2019 | 88 | 0.040 |
Why?
| Lung | 1 | 2023 | 490 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 224 | 0.040 |
Why?
| Thinness | 1 | 2019 | 45 | 0.040 |
Why?
| Medicaid | 1 | 2021 | 257 | 0.040 |
Why?
| Specimen Handling | 1 | 2018 | 55 | 0.040 |
Why?
| Extracellular Matrix | 1 | 2019 | 111 | 0.040 |
Why?
| Pregnancy Trimester, First | 1 | 2018 | 22 | 0.040 |
Why?
| Bacteroides | 1 | 2018 | 14 | 0.040 |
Why?
| Survival Rate | 1 | 2021 | 901 | 0.040 |
Why?
| Cell Nucleus | 1 | 2019 | 187 | 0.040 |
Why?
| Feeding Behavior | 1 | 2020 | 177 | 0.040 |
Why?
| Cell Transformation, Neoplastic | 1 | 2019 | 179 | 0.040 |
Why?
| Mass Spectrometry | 1 | 2019 | 301 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 590 | 0.040 |
Why?
| Africa | 1 | 2017 | 10 | 0.040 |
Why?
| Asia | 1 | 2017 | 18 | 0.040 |
Why?
| Temperature | 1 | 2018 | 168 | 0.040 |
Why?
| Superoxides | 1 | 2018 | 46 | 0.040 |
Why?
| Selection, Genetic | 1 | 2017 | 23 | 0.040 |
Why?
| Brazil | 1 | 2017 | 35 | 0.040 |
Why?
| RNA Stability | 1 | 2017 | 24 | 0.040 |
Why?
| Gene Dosage | 1 | 2018 | 78 | 0.040 |
Why?
| Synteny | 1 | 2017 | 7 | 0.040 |
Why?
| Physicians | 1 | 2021 | 230 | 0.040 |
Why?
| Clostridium thermocellum | 1 | 2017 | 3 | 0.040 |
Why?
| Bacterial Toxins | 1 | 2018 | 52 | 0.040 |
Why?
| Comorbidity | 1 | 2019 | 613 | 0.040 |
Why?
| Neurogenesis | 1 | 2017 | 27 | 0.040 |
Why?
| Cell Lineage | 1 | 2017 | 84 | 0.040 |
Why?
| Adaptation, Physiological | 1 | 2017 | 91 | 0.040 |
Why?
| Computer Graphics | 1 | 2017 | 9 | 0.040 |
Why?
| Clostridium Infections | 1 | 2018 | 53 | 0.040 |
Why?
| Erythropoiesis | 1 | 2017 | 16 | 0.040 |
Why?
| Leukotrienes | 1 | 2017 | 9 | 0.040 |
Why?
| Systems Analysis | 1 | 2016 | 7 | 0.040 |
Why?
| Prostaglandins | 1 | 2017 | 20 | 0.040 |
Why?
| Aorta | 1 | 2018 | 162 | 0.040 |
Why?
| Adaptive Immunity | 1 | 2016 | 32 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 2019 | 428 | 0.030 |
Why?
| Hematopoiesis | 1 | 2017 | 71 | 0.030 |
Why?
| Nicaragua | 1 | 2016 | 2 | 0.030 |
Why?
| Phosphorylation | 1 | 2017 | 534 | 0.030 |
Why?
| Mitochondria, Muscle | 1 | 2016 | 38 | 0.030 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2016 | 3 | 0.030 |
Why?
| Remission, Spontaneous | 1 | 2016 | 25 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2016 | 85 | 0.030 |
Why?
| Fasting | 1 | 2016 | 70 | 0.030 |
Why?
| RNA, Plant | 1 | 2015 | 7 | 0.030 |
Why?
| Pseudomonas fluorescens | 1 | 2015 | 4 | 0.030 |
Why?
| Rhizosphere | 1 | 2015 | 5 | 0.030 |
Why?
| Pseudomonas putida | 1 | 2015 | 5 | 0.030 |
Why?
| Diploidy | 1 | 2015 | 26 | 0.030 |
Why?
| Staining and Labeling | 1 | 2016 | 97 | 0.030 |
Why?
| Sequence Analysis, Protein | 1 | 2015 | 19 | 0.030 |
Why?
| Plant Roots | 1 | 2015 | 33 | 0.030 |
Why?
| Panicum | 1 | 2015 | 1 | 0.030 |
Why?
| Cellulase | 1 | 2015 | 2 | 0.030 |
Why?
| Muscle Fibers, Skeletal | 1 | 2016 | 62 | 0.030 |
Why?
| Filoviridae | 1 | 2015 | 5 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2015 | 82 | 0.030 |
Why?
| Tumor Burden | 1 | 2016 | 131 | 0.030 |
Why?
| Plants | 1 | 2015 | 28 | 0.030 |
Why?
| Epinephrine | 1 | 2016 | 96 | 0.030 |
Why?
| Cations, Divalent | 1 | 2015 | 6 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1378 | 0.030 |
Why?
| Pseudomonas aeruginosa | 1 | 2015 | 72 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2016 | 236 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2015 | 38 | 0.030 |
Why?
| Virulence Factors | 1 | 2016 | 78 | 0.030 |
Why?
| Cathepsin D | 1 | 2014 | 4 | 0.030 |
Why?
| Thioglycolates | 1 | 2014 | 5 | 0.030 |
Why?
| Polysaccharides | 1 | 2015 | 51 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 601 | 0.030 |
Why?
| Genome, Archaeal | 1 | 2014 | 11 | 0.030 |
Why?
| Vaccination | 1 | 2016 | 271 | 0.030 |
Why?
| Disease Progression | 1 | 2017 | 831 | 0.030 |
Why?
| Risk Assessment | 1 | 2019 | 1262 | 0.030 |
Why?
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 8 | 0.030 |
Why?
| Butyrates | 1 | 2014 | 31 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2014 | 26 | 0.030 |
Why?
| Hardness | 1 | 2013 | 1 | 0.030 |
Why?
| Adiposity | 1 | 2015 | 133 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2014 | 190 | 0.030 |
Why?
| Models, Molecular | 1 | 2015 | 341 | 0.030 |
Why?
| Weaning | 1 | 2013 | 28 | 0.030 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2013 | 2 | 0.030 |
Why?
| Esters | 1 | 2013 | 22 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 193 | 0.030 |
Why?
| Weight Gain | 1 | 2015 | 239 | 0.030 |
Why?
| Fatty Acids, Omega-6 | 1 | 2013 | 2 | 0.030 |
Why?
| Isotope Labeling | 1 | 2014 | 53 | 0.030 |
Why?
| Sweden | 1 | 2013 | 9 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2014 | 110 | 0.030 |
Why?
| Cell Size | 1 | 2013 | 45 | 0.030 |
Why?
| Ergosterol | 1 | 2013 | 10 | 0.030 |
Why?
| Macrophages | 1 | 2016 | 363 | 0.030 |
Why?
| Bioengineering | 1 | 2013 | 3 | 0.030 |
Why?
| NADP | 1 | 2013 | 22 | 0.030 |
Why?
| Tibia | 1 | 2013 | 116 | 0.030 |
Why?
| Cell Separation | 1 | 2013 | 90 | 0.030 |
Why?
| G(M2) Ganglioside | 1 | 2013 | 1 | 0.030 |
Why?
| Keratan Sulfate | 1 | 2013 | 1 | 0.030 |
Why?
| Androsterone | 1 | 2013 | 2 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 665 | 0.030 |
Why?
| Penicillins | 1 | 2013 | 28 | 0.030 |
Why?
| Heparitin Sulfate | 1 | 2013 | 9 | 0.030 |
Why?
| Classification | 1 | 2013 | 14 | 0.030 |
Why?
| Insulin-Like Growth Factor I | 1 | 2013 | 138 | 0.030 |
Why?
| Demography | 1 | 2013 | 92 | 0.030 |
Why?
| Species Specificity | 1 | 2013 | 192 | 0.030 |
Why?
| Chemotaxis, Leukocyte | 1 | 2012 | 13 | 0.030 |
Why?
| Carbon Cycle | 1 | 2012 | 4 | 0.030 |
Why?
| Environment | 1 | 2013 | 83 | 0.030 |
Why?
| Milk | 1 | 2013 | 79 | 0.030 |
Why?
| Aerosols | 1 | 2013 | 73 | 0.030 |
Why?
| Lumbar Vertebrae | 1 | 2013 | 98 | 0.030 |
Why?
| Complement Activation | 1 | 2012 | 42 | 0.030 |
Why?
| Esterification | 1 | 2012 | 6 | 0.030 |
Why?
| Genetic Markers | 1 | 2012 | 102 | 0.030 |
Why?
| Xylose | 1 | 2012 | 4 | 0.030 |
Why?
| Leptin | 1 | 2013 | 140 | 0.030 |
Why?
| Inflammatory Bowel Diseases | 1 | 2013 | 53 | 0.030 |
Why?
| Bioreactors | 1 | 2012 | 10 | 0.030 |
Why?
| Eubacterium | 1 | 2012 | 1 | 0.030 |
Why?
| Survival Analysis | 1 | 2014 | 666 | 0.030 |
Why?
| beta Carotene | 1 | 2012 | 8 | 0.030 |
Why?
| Actinobacteria | 1 | 2012 | 8 | 0.030 |
Why?
| Peptidoglycan | 1 | 2012 | 12 | 0.030 |
Why?
| Sepsis | 1 | 2014 | 221 | 0.020 |
Why?
| Oxidoreductases | 1 | 2012 | 60 | 0.020 |
Why?
| Immunity, Cellular | 1 | 2011 | 70 | 0.020 |
Why?
| Administration, Intravaginal | 1 | 2011 | 8 | 0.020 |
Why?
| Biological Phenomena | 1 | 2011 | 3 | 0.020 |
Why?
| Treatment Outcome | 1 | 2021 | 5155 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 512 | 0.020 |
Why?
| Body Composition | 1 | 2013 | 319 | 0.020 |
Why?
| Chronic Disease | 1 | 2013 | 571 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2010 | 40 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2012 | 487 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 232 | 0.020 |
Why?
| Protein Interaction Mapping | 1 | 2010 | 40 | 0.020 |
Why?
| Age Factors | 1 | 2013 | 1092 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2013 | 978 | 0.020 |
Why?
| Databases, Factual | 1 | 2013 | 657 | 0.020 |
Why?
| Body Mass Index | 1 | 2013 | 656 | 0.020 |
Why?
| Oxygen | 1 | 2012 | 325 | 0.020 |
Why?
| Retrospective Studies | 1 | 2021 | 6134 | 0.020 |
Why?
| Binding Sites | 1 | 2010 | 375 | 0.020 |
Why?
| Glucose | 1 | 2010 | 338 | 0.020 |
Why?
| Ethanol | 1 | 2010 | 341 | 0.020 |
Why?
|
|
Nookaew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|